|
African Journal of Biomedical Research
Ibadan Biomedical Communications Group
ISSN: 1119-5096
Vol. 7, Num. 1, 2004, pp. 37-39
|
African Journal of Biomedical Research, Vol.
7, No. 1, Jan, 2004, pp. 37-39
Short communication
CROSSREACTIVITY
OF BOAR SPERM MONOCLONAL ANTIBODIES
WITH HUMAN SPERMATOZOA
OLUREMI E. FAYEMI
Department of Veterinary
Surgery & Reproduction, University of Ibadan, Ibadan, Nigeria.
Received: Jan 2002
Accepted in final form: June 2002
Code Number: md04010
Monoclonal antibodies against the
head (H mabs) and tail (Tmabs) of boar spermatozoa were produced. Spermatozoa
from boar, stallion, bull, human, ram, goat and rabbit were independently incubated
with the monoclonal antibodies and later stained by immunofluorescence method.
There were positive reactions of the monoclonal antibodies with the boar and
human spermatozoa. There was no reaction with spermatozoa of all the other species.
The crossreactivity observed between the sperm antibodies of boar and human spermatozoa
may open up research efforts on
non-steroidal contraceptives in humans.
Key Words: Boar
spermatozoa antibodies human
cross- reactivity.
INTRODUCTION
Monoclonal antibodies had been
used as probes for biological structures (Kohler and Milstein, 1975, Lee et.
al., 1984) especially to study the reproductive system in many areas of research
such as cell biology, endocrinology, immunogenetics and pathology (Bellve and
Moss, 1983). Monoclonal antibodies had been produced against sperm in the baboon
(Isahakia, 1986), mouse (Saling et al, 1985), rat (Gaunt et al, 1983) rabbit
(Naz et al, 1983)
and boar (Fayemi and Joo, 1990). These monoclonal antibodies were specific for
different parts of the sperm cell.
There had been clamour
for human population control in the last few decades and various methods, surgical
and non-surgical had been
used for this purpose. These methods include vasectomy and the use of condom
in the male and implants, intrauterine device and steroidal contraceptives in
the female. These methods especially steroidal contraceptives have been noted
to have some unfavourable side effects like pulmonary embolism and cerebral thromhosis
(Tatum 1985).
Since sperm antibodies
had been associated with infertility in human males (Paul et al, 1983, Haas
et al, 1980) and females
(Menge et al. 1982, Clarke et. al., 1995)), It is believed that sperm antigens
or antibodies can be useful for contraception and thereby side-tract the side
effects of steroidal contraception (Rieder and Coupey, 1999, Shetty et. al.,
1999). Boar semen can be easily collected in large volume and therefore can
be
of commercial value if found useful in contraception.
The objective of this study
was to check whether monoclonal antibodies to boar sperm can specifically bind
to the surface antigens of the human sperm and it is believed that if this
is achievable it may thereafter block the fertilization capacity or reduce
motility of the sperm
cells thereby becoming a useful contraceptive device.
MATERIALS AND METHODS
Preparation of Antigen: Monoclonal
antibodies to boar
spermatozoa were prepared as described below:
Semen collected from four
adult boars and pooled into a flask was centrifuged at 1200g for 5 minutes
to separate the spermatozoa
from the seminal plasma. The spermatozoa were then washed three times in 0.005M
phosphate buffered saline (PBS) and resuspended at a concentration of 1
x 109 cells/ml. The cells were then sonicated over a period of one
minute with sonicator model W380 (Heat Systems Ultrasonic Inc.) and mixed with
equal volume of either complete or incomplete Freunds adjuvant.
Immunization of Mice: Mice
of the BALB/C strains were injected intraperitonially with 2ml of the mixture
of sonicated sperm cells and complete adjuvant on day 0, mixture of sperm cells
with incomplete adjuvant on day 14 and sonicated cells alone on day 24 and
the spleens removed, minced and the spleen cells suspended in RPMI-1640 {Gibco},
48
hours after the last injection.
Fusion of Cells: The
spleen cell suspension in RPMI-1640 (Gibco) was put into 50ml sterile tube
and myeloma
cells Ag8.653 were harvested into another 50ml sterile tube. The two preparations
were washed three times with serum-less RPMI 1640 at 40C.
The cells were counted
and mixed in a spleen cells to Ag8.653 ratio of 2:1. The cell mixture was
washed by centrifugation in serum -free RPMI 1640 at 500g for 7 minutes, aspirating
the supernatant, loosening the pellet and slowly adding polyethylene glycol
(PEG) over a period of 45 seconds. The PEG was prepared by weighing 20gm, PEG
4000 which was autoclaved in 100ml bottle before adding 28ml sterile Dubelccos
phosphate buffered saline (DPBS) containing 15% Diethylsulfoxide (DMSO). The
mixture was diluted by dropwise addition of 20ml serum-free RPMI 1640 at 37oC
before filling the tube to 50ml with the RPMI 1640. This was then centrifuged
at 500g for 10minutes and resuspended in sterilized Hypoxanthine and Thymidine
(HT) medium prepared by dissolving 272.2mg hypoxanthine (Sigma) and 7.75mg
thymidine (Sigma) in 20mls distilled water at pH8.1, at 37oC.
The final concentration
was
then adjusted to 1.5 x 105 spleen cells/ml. Peritoneal wash of one
normal mouse using 100mls RPMI-1640 was added and mixed before dispensing into
96 well plates. Each well thus contained approximately 5 x 105 spleen
cells. The plates were incubated in 10% CO2 at 37oC. HAT, (Hypoxanthine
Aminopterin Thymidine), prepared with 1ml HT + 1ml Aminopterin
(Lederle) made up to 100ml in complete media which was a mixture of 100ml RPMI-1640,
20ml, Fetal calf serum (FCS), 2μm Glutamine, 50µm 2-mercaptoethanol, 1ml
penicillin streptomycin and 2µm Fungizone, was added at 2 drops/well on Day
1.
The plates were observed
with
inverted microscope on Day 5 to check for myelona cell death and
contamination. Copper sulphate solution was used to kill contaminated cells. On
Day 14, 0.5ml supernatant was removed and discarded from each well and replaced
with 0.5ml/well complete media. This process of using complete media to replace
discarded supernatant was repeated on Days 17 to 21.
The plates were scored
for
hybridoma growth and the supernatant tested for antibody production on days
21
to 23. The monoclonal antibody production was tested by the indirect immunofluorescence
technique as described for spermatozoa by Lee et al., 1984.
Two of the monoclonal antibodies,
anti Head and anti-Tail
were collected and stored at -20oC until ready for use.
Preparation of Sperm
Cells of
other Species
Semen was collected from
ram, goat, buck, bull, boar
and human. The method of collection for the ram, goat, buck and bull was by
the use of artificial vagina, the boar by the gloved hand method, the stallion
by the use of polythene nylon as condom and semen from human was donated by volunteers
using condoms. The semen collected were kept at 37oC before washing
in the laboratory. The semen samples from each species were pooled and centrifuged
at 1200g for 5 minutes, resuspended each time in PBS and
centrifuged three times. The cells were resuspended at a concentration of 1
x
106 cells/µl. The final resuspended sperm cells were used to make
smears on clean glass slides. The slides were fixed in methanol for 5 minutes
and then incubated with 1% bovine serum albumin (BSA, Sigma) for 2 hours before
washing for 15 minutes in PBS.
Incubation with Boar
Sperm
Monoclonal antibodies
The two boar sperm monoclonal
antibodies were applied separately on the sperm slides for each of the species
and incubated
for 24hrs at 4oC. The slides were washed in PBS for 15 minutes and
then incubated with 1:600 FITC conjugated goat-anti-mouse 1gG for 1 hour at 37oC. The
slides were later washed in PBS for 15minutes, mounted and observed under fluorescent
microscope.
RESULTS
The two Mabs, H (anti-head)
and T (anti-tail) as expected reacted with the porcine sperm, but also cross-reacted
with the human
spermatozoa. The staining of the H was more intense than T. There was no cross-reaction
observed with the equine, bovine, ovine and caprine spermatozoa as there was
no immunofluorescence observed after the staining in these
species.
DISCUSSION
The results demonstrated
cross reactivity of boar
sperm monoclonal antibodies with human sperm. This suggests that boar sperm
antigens and antibodies to them may be candidates for non-steroidal contraception
in humans. Steroidal contraceptives have been reported to have possible relationship
with the incidence of thromboembolic diseases, including pulmonary embolism and
cerebral thrombosis, and cancer of the endometrium
(Tatum, 1985). Attempts have been made to get alternative contraceptives that
will be safer.
The anti-head
mab will probably be useful in the blockade of fertilizing capacity of sperm
by causing head to head (H-H) agglutination (Boettcher et. al., 1977) inactivation
of acrosomal enzymes
like hyahuronidase and acrosin which are involved in sperm penetration of the
investment surrounding the egg (Bellve and OBrien, 1983, Archibong et. al. 1995,
Kadam, et. al. 1995). The anti-head antibody may also block binding sites of
sperm to egg membranes thereby preventing fertilization (Menge, 1971, Clarke
et. al., 1985, ORand and Porter, 1979, Castle et. al. 1997). The anti Tail
mab will affect fertility via the inhibition of sperm motility (Methur et. al.,
1984, Mathur et. al., 1986). The crossreactivity if further investigated may
open the gate for the use of porcine sperm cells or the monoclonal antibodies,
when purified to be cheaper because the boar semen can be obtained in large quantity
per ejaculate from a large population of swine
animals. This will also be safer because it will be devoid of the side effects
of steroidal contraceptives mentioned earlier.
In conclusion, it is believed
that the porcine semen may become useful in human population control but more
work needs to be done to
guarantee safety from other unforeseen side effects.
ACKNOWLEDGEMENT
The project was carried out
from funds provided for other
related projects by the Minnesota Swine Producers Association.
REFERENCES
-
Archibong, A. E., Lee, C. Y.
and Wolf, D. P. (1995). Functional characterization of the primate sperm
acrosomal antigen (PSA 63). J. Androl. 16: 318 326.
-
Bellve, A. R. and Moss, S. B.
(1983). Monoclonal antibodies as probes of reproductive mechanisms.
Biol. Reprod. 28: 1 26.
-
Bellve, A. R. and OBrien, D.
A. (1983). The mammalian spermatozoa. In: Mechanism and control of
animal fertilization. Hartmann, J. F. (ed.). Academic Press, New York.
pp. 55-137.
-
Boettcher, B., Hjort, T., Rumke,
P., Shulman, S. and Vyazov,
O. E. (1977). Auto and iso antibodies to antigens of the human reproductive
system. I. Results of an international cooperative study. Clin. Exp.
Immunol. 30:
173-180.
-
Castle, P. E., Whaley, K. J.,
Hoen, T. E., Moench, T. R. and
Cone, R. A. (1997). Contraceptive effect of sperm-agglutinating monoclonal
antibodies in rabbits. Biol. Reprod.
56: 153-159.
-
Clarke, G. N., Elliot, P.J.
and Smaila, C. (1985). Detection of sperm antibodies in semen using
the Immunobead test: A survey of 813 consecutive patients. Am. J. Reprod.
Immunol. Microbiol. 7: 118 123.
-
Fayemi, O. and Joo, H.S. (1990). Effects
of monoclonal antibodies to boar sperm on the filterability of the sperm
through sephadex column. Zariya
Vet. 5: 30-36.
-
Gaunt, S. J., Brown, C. R. and
Jones, R. (1983). Identification of mobile and fixed antigens on the
plasma membrane of rat spermatozoa using monoclonal
antibodies. Exp. Cell Res. 144: 275 284.
-
Haas, G. G., Cines, D. B. and
Schrieber, A. D. (1980). Immunologic infertility: Identification of
patients with antisperm antibodies. New Engl. J. Med. 303:
722 727.
-
Isahakia, M. (1986). Characterization
of babeon testicular antigens using monoclonal anti-sperm antibodies. J. Reprod.
Immunol. (Suppl.) 9: 30.
-
Kohler, G. and Milstein, C.
(1975): Continuous cultures of fused cells secreting antibody of
predefined specificity. Nature 256: 495 - 497.
-
Kadam, A. L., Fateh, M. and
Naz, R. K. (1995). Fertilization antigen (FA-1) completely blocks human
sperm binding to human zona pellucida; FA 1 antigen may be a sperm receptor
for zona pellucida in humans. J. Reprod.. Immunol. 29:
19 30.
-
Lee, C.Y.G., Wang, E. and Teh,
C.Z. (1984). Analysis of mouse sperm isoantigens using specific monoclonal
antibodies. Am. J. Reprod. Immunol. 6: 37-43.
-
Mathur, S., Williamson, H. O.,
Baker, M. E., Rust, P. F.,
Holtz, G. L. and Fudenberg, H. H. (1984). Sperm motility on postcoital testing
correlates with
male autoimmunity to sperm. Fertil. Steril. 41: 81 87.
-
Mathur, S., Carlton,
B. M., Zeigler, J. and Williamson, H. O. (1986). Motion characteristics
of spermatozoa
from men with cytotoxic sperm antibodies. Am. J. Reprod. Immunol. Microbial.
12: 87 90.
-
Menge, A. C. (1971). Effects
of isoimmunization and isoantisera against seminal antigens on fertility
process in female rabbits. Proc. Soc. Exp. Biol. Med.
138: 98-102
-
Menge, A. C., Medley, N. E.,
Mangione, C. M. and Dietrich,
J.W. (1982). The incidence and influence of antisperm antibodies in infertile
human couples on
sperm-cervical mucus interactions and subsequent fertility . Fertil. Steril.
38: 439 446.
-
Naz, R. K., Saxe, J. M. and
Menge, A. C. (1983). Inhibition of fertility in rabbits by monoclonal
antibodies against sperm. Biol. Reprod. 28: 249-254.
-
ORand, M. G. and Porter, P.
(1979). Isolation of a sperm membrane sialo-glycoprotein autoantigen
from rabbit testes. J. Immunol. 122: 1248-1254.
-
Paul, S., Baukloh, V. and Mettler,
L. (1983). Enzyme-linked immunosorbent assays for sperm antibody
detection and antigenic analysis. J. Immunol. Methods 56:
193 199.
-
Rieder, J. and Coupey, S. M.
(1999). The use of non-hormonal methods of
contraception in adolescents. Pediatric Clinics. North America 46: 671 694.
-
Saling, P.M., Irons, G. and
Waibel, R. (1985). Mouse sperm antigens that participate in fertilization.
I. Inhibition of sperm fusion with the eggs plasma membrane using monoclonal
antibodies. Biol. Reprod. 33: 515-526.
-
Shetty, J., Naaby-Hansen, S.,
Shibahara, H., Bronson, R.,
Flickinger, C. J. and Herr, J. C.
-
(1999). Human sperm proteome: immunodominant
sperm surface antigens identified
with sera from infertile men and women. Biol. Reprod. 61: 61 69.
-
Tatum, H. J. (1985). Contraception
and Family planning. In: Current Obstetric
and Gynecologic Diagnosis and Treatment. 5th Edition. Benson, R.
C. (ed.). Lange Medical Publications, Los Altos, California 94022.
pp. 525 555.
© Ibadan Biomedical Communications Group
|